Literature DB >> 24729635

Aromatic interactions impact ligand binding and function at serotonin 5-HT2C G protein-coupled receptors: Receptor homology modeling, ligand docking, and molecular dynamics results validated by experimental studies.

Tania Córdova-Sintjago1, Nancy Villa1, Lijuan Fang1, Raymond G Booth2.   

Abstract

The serotonin (5-hydroxytryptamine, 5-HT) 5-HT2 G protein-coupled receptor (GPCR) family consists of types 2A, 2B, and 2C that share ~75% transmembrane (TM) sequence identity. Agonists for 5-HT2C receptors are under development for psychoses, whereas, at 5-HT2A receptors, antipsychotic effects are associated with antagonists-in fact, 5-HT2A agonists can cause hallucinations and 5-HT2B agonists cause cardiotoxicity. It is known that 5-HT2A TM6 residues W6.48, F6.51, and F6.52 impact ligand binding and function, however, ligand interactions with these residues at the 5-HT2C receptor has not been reported. To predict and validate molecular determinants for 5-HT2C-specific activation, results from receptor homology modeling, ligand docking, and molecular dynamics (MD) simulation studies were compared with experimental results for ligand binding and function at wild type and W6.48A, F6.51A, and F6.52A point-mutated 5-HT2C receptors.

Entities:  

Keywords:  Aromatic Interactions; F6.51; F6.52; GPCR; Serotonin 5-HT2C; W6.48; docking; drug design; homology modeling; molecular dynamics

Year:  2014        PMID: 24729635      PMCID: PMC3979624          DOI: 10.1080/00268976.2013.833656

Source DB:  PubMed          Journal:  Mol Phys        ISSN: 0026-8976            Impact factor:   1.962


  41 in total

1.  Identification of conserved aromatic residues essential for agonist binding and second messenger production at 5-hydroxytryptamine2A receptors.

Authors:  B L Roth; M Shoham; M S Choudhary; N Khan
Journal:  Mol Pharmacol       Date:  1997-08       Impact factor: 4.436

2.  The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure.

Authors:  Tetsuji Okada; Minoru Sugihara; Ana-Nicoleta Bondar; Marcus Elstner; Peter Entel; Volker Buss
Journal:  J Mol Biol       Date:  2004-09-10       Impact factor: 5.469

3.  Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists.

Authors:  Michael R Braden; Jason C Parrish; John C Naylor; David E Nichols
Journal:  Mol Pharmacol       Date:  2006-09-25       Impact factor: 4.436

4.  Crystal structure of the ligand-free G-protein-coupled receptor opsin.

Authors:  Jung Hee Park; Patrick Scheerer; Klaus Peter Hofmann; Hui-Woog Choe; Oliver Peter Ernst
Journal:  Nature       Date:  2008-06-18       Impact factor: 49.962

Review 5.  Therapeutic potential of 5-HT2C receptor ligands.

Authors:  Nanna H Jensen; Thomas I Cremers; Florence Sotty
Journal:  ScientificWorldJournal       Date:  2010-09-14

6.  A homology-based model of the human 5-HT2A receptor derived from an in silico activated G-protein coupled receptor.

Authors:  James J Chambers; David E Nichols
Journal:  J Comput Aided Mol Des       Date:  2002-07       Impact factor: 3.686

7.  Molecular Determinants for Ligand Binding at Serotonin 5-HT2A and 5-HT2C GPCRs: Experimental Affinity Results Analyzed by Molecular Modeling and Ligand Docking Studies.

Authors:  Tania Córdova-Sintjago; Rajeev Sakhuja; Krishnakanth Kondabolu; Clinton E Canal; Raymond G Booth
Journal:  Int J Quantum Chem       Date:  2012-12-15       Impact factor: 2.444

8.  The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.

Authors:  Veli-Pekka Jaakola; Mark T Griffith; Michael A Hanson; Vadim Cherezov; Ellen Y T Chien; J Robert Lane; Adriaan P Ijzerman; Raymond C Stevens
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

9.  Synthesis and pharmacological evaluation of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for a novel receptor with sigma-like neuromodulatory activity.

Authors:  S D Wyrick; R G Booth; A M Myers; C E Owens; N S Kula; R J Baldessarini; A T McPhail; R B Mailman
Journal:  J Med Chem       Date:  1993-08-20       Impact factor: 7.446

10.  Discovery of 1,2,4-triazine derivatives as adenosine A(2A) antagonists using structure based drug design.

Authors:  Miles Congreve; Stephen P Andrews; Andrew S Doré; Kaspar Hollenstein; Edward Hurrell; Christopher J Langmead; Jonathan S Mason; Irene W Ng; Benjamin Tehan; Andrei Zhukov; Malcolm Weir; Fiona H Marshall
Journal:  J Med Chem       Date:  2012-01-27       Impact factor: 7.446

View more
  6 in total

1.  Insights into the influence of 5-HT2c aminoacidic variants with the inhibitory action of serotonin inverse agonists and antagonists.

Authors:  Roberta Galeazzi; Luca Massaccesi; Francesco Piva; Giovanni Principato; Emilioano Laudadio
Journal:  J Mol Model       Date:  2014-02-22       Impact factor: 1.810

2.  Serotonin-2C and -2a receptor co-expression on cells in the rat medial prefrontal cortex.

Authors:  C Nocjar; K D Alex; A Sonneborn; A I Abbas; B L Roth; E A Pehek
Journal:  Neuroscience       Date:  2015-03-27       Impact factor: 3.590

3.  Aromatic interactions at the ligand-protein interface: Implications for the development of docking scoring functions.

Authors:  Michal Brylinski
Journal:  Chem Biol Drug Des       Date:  2017-08-31       Impact factor: 2.817

4.  Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.

Authors:  Clinton E Canal
Journal:  Handb Exp Pharmacol       Date:  2018

5.  Novel 4-substituted-N,N-dimethyltetrahydronaphthalen-2-amines: synthesis, affinity, and in silico docking studies at serotonin 5-HT2-type and histamine H1 G protein-coupled receptors.

Authors:  Rajeev Sakhuja; Krishnakanth Kondabolu; Tania Córdova-Sintjago; Sean Travers; Adam S Vincek; Myong Sang Kim; Khalil A Abboud; Lijuan Fang; Zhuming Sun; Clinton E Canal; Raymond G Booth
Journal:  Bioorg Med Chem       Date:  2015-02-07       Impact factor: 3.641

6.  Similarities between the Binding Sites of SB-206553 at Serotonin Type 2 and Alpha7 Acetylcholine Nicotinic Receptors: Rationale for Its Polypharmacological Profile.

Authors:  Patricia Möller-Acuña; J Sebastián Contreras-Riquelme; Cecilia Rojas-Fuentes; Gabriel Nuñez-Vivanco; Jans Alzate-Morales; Patricio Iturriaga-Vásquez; Hugo R Arias; Miguel Reyes-Parada
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.